Balentine LLC’s Bio-Techne TECH Stock Holding History

Balentine LLC’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-6,105	Closed	-$430K	–	528
2024 Q1	$430K	Buy	6,105 +378	+7%	+$27K	0.01%	322
2023 Q4	$442K	Buy	+5,727	New	+$377K	0.01%	302

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Balentine LLC's TECH Position: Q2 2024 in Review

Balentine LLC sold out of Bio-Techne (TECH) in Q2 2024, closing a stake of 6,105 shares — an estimated $430K sold.

Balentine LLC first reported a position in TECH in Q4 2023 and held it in 2 quarters. The position peaked at $442K in Q4 2023. 572 funds tracked by Wall St. Rank hold TECH as of Q2 2024.

Balentine LLC reported no remaining Bio-Techne position as of Q2 2024 after selling out during the quarter.
Balentine LLC sold 6,105 Bio-Techne shares in Q2 2024, an estimated $430K.
Balentine LLC first reported a position in Bio-Techne in Q4 2023 and held it in 2 quarters.
Balentine LLC's Bio-Techne position peaked at $442K in Q4 2023.
572 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2024.

Based on Balentine LLC's 13F filing for Q2 2024, filed 7 Aug 2024.